EXOMETA for Regenerative Healing and Vitality

Harnessing the power of exosomes from Human Umbilical Cord Wharton’s Jelly and endothelial progenitor cells, EXOMETA targets diabetic conditions, stroke, neuro-degenerative, and other age-related chronic diseases.

Designed to accelerate healing and restore vitality, EXOMETA is at the forefront of advanced regenerative therapies. Our approach adheres to service-based research (penelitian berbasis pelayanan) guidelines, as currently mandated by government regulations, allowing applications in clinics with at least a "klinik utama" license.